Miss Hu Mengjin

Miss Hu Mengjin

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

Meng-Jin Hu, a graduate student comes from State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College. Her major is in coronary artery disease.

Presentations

The optimal duration of dual antiplatelet therapy after PCI with drug-eluting stent: a systematic review and Bayesian network meta-analysis

Event: EHRA 2022

Topic: Prevention

Session: ePosters Day 2

Access

Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? a systematic review and meta-analysis

Event: ESC Preventive Cardiology 2021

Topic: Clinical

Session: ePosters

Access

Miss Hu Mengjin

Biography

Contributor content

The optimal duration of dual antiplatelet therapy after PCI with drug-eluting stent: a systematic review and Bayesian network meta-analysis

Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? a systematic review and meta-analysis

ESC 365 is supported by